New AI-powered capabilities within the ACTO platform increase field team efficiency, consistency, and impact by streamlining workflow while keeping humans in control
TORONTO and NEW YORK– March 16, 2026 — ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced the launch of ACTO AI, a powerful new suite of AI capabilities designed to streamline and automate critical workflows across the ACTO platform. Built specifically for pharmaceutical, biotech, and medtech organizations, ACTO AI accelerates training development, certification, and content management for commercial learning and development teams. It also empowers field managers, sales professionals, and medical science liaisons with faster information retrieval, more effective field coaching, and deeper data insights.
“ACTO AI helped us certify more than 85 field professionals on TYMLOS messaging with greater speed and consistency,” said Sal Christina, Associate Director of Sales Training at Radius Health. “The AI-generated recommendations made it much easier for our proctors to review submissions while still giving them the final decision on approvals. It’s been a huge time saver for our Commercial Learning & Development team.”
ACTO AI Workflow Impact
ACTO AI automates and streamlines workflows that previously required a heavy manual lift:
- Learning Program & Content Creation: Instantly accelerates the creation of training courses, scenarios, AI roleplay simulations, quizzes, certifications, and entire learning programs.
- Certification: Streamlines the evaluation process, standardizing how certifications are reviewed and scored to ensure consistency across the organization.
- Content Governance: Automates the most tedious parts of asset management, including nomenclature cleanup, identifying duplicate files, and managing content expiry dates.
- Coaching & Reporting: Automates the drafting and review of field coaching reports, ensuring feedback is captured and deployed without administrative lag.
- Information Retrieval: Provides a natural-language search layer for end users to find critical content instantly within the platform.
- Strategic Insight: Adds a natural language layer on top of dashboards and field data that allows senior leaders to accelerate insights through conversational queries.
“ACTO AI was inspired by what we’ve seen firsthand in the ACTO community—more than 50,000 field professionals and 5,000 administrators using the platform every day to drive field excellence,” said Parth Khanna, CEO of ACTO. “Through thousands of customer conversations and hundreds of executive business reviews, we identified the high-friction workflows that consume valuable time and slow momentum around product launches, new hire onboarding, and field execution. We built ACTO AI to eliminate that friction—helping our customers move beyond managing workflows to delivering real impact.”
As life sciences organizations face increasing pressure to bring therapies and technologies to market faster despite growing human capital gaps, ACTO AI delivers intelligent workflow automation that keeps humans in control and drives measurable impact for field teams.
For more information or to request a demo, visit www.acto.com/AI
Visit www.acto.com, or follow ACTO on LinkedIn for the latest company announcements and news.
About ACTO
Trusted by 14 of the top 50 pharmaceutical companies, high-growth biotechs, and leading medtech organizations, ACTO is redefining how therapies reach patients after regulatory approval. We unite human intelligence with empathetic AI through our AI-powered Field Excellence Platform and AI SuperAgents to accelerate product launches, strengthen field execution, and deepen customer engagement. By elevating training and coaching while agentifying up to 30% of the work embedded in customer-facing roles, ACTO frees teams to focus on what matters most: human connection, judgment, and strategic execution. Built to meet the industry’s highest regulatory standards, ACTO is FDA 21 CFR Part 11 validated and SOC 2 Type II certified. Learn more at www.acto.com.